Compared with twice-daily NPH , once-daily glargine treatment resulted in significantly lower adjusted odds ratios ( OR ) for all daytime hypoglycemia ( OR @ ; p = @ ) and any severe event ( OR @ ; p = @ ) , representing a @ % and @ % reduction in the odds of daytime and severe hypoglycemia , respectively .